NASDAQ: IMA
ImageneBio Inc
$4.87
▼ -0.09 (-1.81%)as of 2026-09-03
1-year price · 252 sessions
Key stats
52-week range$4.87
$4.55$9.29
Today
- Open
- 4.87
- Day high
- 4.94
- Day low
- 4.81
- Prev close
- 4.96
- Volume
- 11K
Valuation
- Mkt cap
- $55M
- P/E (TTM)
- —
- EPS (TTM)
- —
- P/B
- 0.4
- P/S
- —
Dividend
- Yield
- —
- Per share
- —
Insider & institutional activity · SEC Form 4 / 13F
- ▼Insiders net selling -$17K over the last 3 months (0 open-market buys, 2 sales)
- 🏛Institutions reducing (13F)
ImageneBio Inc (IMA) is a Healthcare company listed on NASDAQ. The stock is down 42% over the past year. Over the trailing 3 months, insiders filed 0 open-market buys and 2 sales (SEC Form 4).
ImageneBio Inc (IMA) financials & analyst ratings
Fundamentals (TTM)
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
Growth & returns
Revenue growth—
Revenue growth (fwd)—
EPS growth-3.4%
Return on equity-36.9%
Return on assets-34.5%
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
IMA earnings date, history & EPS estimates
Next earnings
Nov 11, 2026in NaN days
EPS est $-0.83 · Revenue est —
Track record
Beat EPS in 9 of 12 quarters
Avg surprise -10.3% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 5, 2026 | $-0.98 | $-0.63 | +35.5% | — | — |
| May 7, 2026 | $-0.70 | $-0.95 | -35.7% | — | — |
| Nov 12, 2025 | $-1.47 | $-2.91 | -98.0% | — | — |
| Jul 24, 2025 | $-0.14 | $-0.06 | +57.1% | — | — |
| May 8, 2025 | $-0.21 | $-0.18 | +14.3% | — | — |
| Mar 6, 2025 | $-0.19 | $-0.18 | +5.3% | — | — |
| Nov 7, 2024 | $-0.27 | $-0.19 | +29.6% | — | — |
| Aug 8, 2024 | $-0.31 | $-0.27 | +12.9% | — | — |
| Mar 12, 2024 | $-0.41 | $-0.41 | +0.0% | $659000 | -79.0% |
| Nov 9, 2023 | $-0.44 | $-0.40 | +9.1% | $1M | -57.8% |
| Aug 10, 2023 | $-0.48 | $-0.44 | +8.3% | $2M | -34.9% |
| May 15, 2023 | $-0.46 | $-0.39 | +15.2% | $5M | +15.2% |
IMA insider trading activity (SEC Form 4)
Sentiment
0/100
Buys (3m)
0
Sells (3m)
2
Net (3m)
-$17.3K
Insider trades by month Buys Sells
Jan
Jun
Jul
Dec
Apr
Jul
Context3-month price -14.2%Institutions reducing (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 17, 2026 | Grant-Huerta Yaninaofficer: Chief Financial Officer | Grant | 65,000 | — |
| Aug 17, 2026 | Grant-Huerta Yaninaofficer: Chief Financial Officer | Grant | 39,000 | — |
| Aug 17, 2026 | Grant-Huerta Yaninaofficer: Chief Financial Officer | Grant | 56,000 | $5.84 |
| Aug 17, 2026 | Yarema Kristindirector, officer: Chief Executive Officer | Grant | 254,800 | — |
| Aug 17, 2026 | Yarema Kristindirector, officer: Chief Executive Officer | Grant | 137,200 | $5.84 |
| Aug 17, 2026 | Yarema Kristindirector, officer: Chief Executive Officer | Grant | 250,000 | $5.84 |
| Jul 28, 2026 | Yarema Kristindirector, officer: Chief Executive Officer | Option | 38,376 | — |
| Jul 20, 2026 | Lally Robert Bofficer: Principal Accounting Officer | Sell | 1,671 | $5.50 |
| Jul 20, 2026 | Lally Robert Bofficer: Principal Accounting Officer | Sell | 1,525 | $5.34 |
| Jun 18, 2026 | SLATTERY JOSEPH Pdirector | Grant | 15,600 | $5.45 |
| Jun 18, 2026 | Stampacchia Otellodirector | Grant | 15,600 | $5.45 |
| Jun 18, 2026 | Wang Jonathan Jiandirector | Grant | 15,600 | $5.45 |
| Jun 18, 2026 | Bonita David Pdirector | Grant | 15,600 | $5.45 |
| Apr 16, 2026 | Bonita David Pdirector | Buy | 384,689 | $0.00 |
| Apr 16, 2026 | ORBIMED ADVISORS LLCdirector | Buy | 336,603 | $0.00 |
Source: IMA SEC Form 4 filings, latest Aug 17, 2026. For informational purposes only — not investment advice.
See the full IMA insider & 13F page →Track IMA with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free